查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2023565

單細胞體學市場分析及至2035年預測：按類型、產品、技術、應用、最終用戶和設備分類

Single-cell Omics Market Analysis and Forecast to 2035: Type, Product, Technology, Application, End-User, Instruments
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球單細胞體學市場預計將從2025年的22億美元成長到2035年的體學億美元，複合年成長率（CAGR）為13.5%。這一成長主要得益於基因組學和精準醫療領域投資的不斷增加。根據美國國立衛生研究院（NIH，2025）的數據顯示，美國每年撥款超過38億美元用於相關研究項目，包括基因組學和單細胞研究。世界衛生組織（WHO，2024）報告稱，全球新增癌症病例超過2000萬例，推動了腫瘤學領域對單細胞分析的需求。此外，歐盟委員會（Horizo​​​​n Europe，2025）已承諾投入約960億美元用於研究和創新，包括生命科學和體學技術。英國舉措 ，2025）持續擴建，目前已擁有超過50萬名參與者，為大規模單細胞和基因組研究計畫提供支援。

單細胞體學市場應用領域涵蓋腫瘤學、細胞生物學、免疫學、神經病學等多個研究領域。其中，腫瘤學是推動市場成長的主要動力，預計2025年市場規模將達到約4.511億美元。這主要歸功於單細胞定序技術在腫瘤異質性分析、生物標記發現以及精準腫瘤學應用的日益普及。細胞生物學則專注於在單細胞層面上闡明細胞結構、功能和基因表現。隨著研究人員對免疫細胞動態、疾病機制和疫苗反應的深入探索，免疫學領域的應用也迅速擴展。神經病學領域也日益受到關注，腦部疾病和神經定位研究不斷深入。此外，發育生物學和感染疾病研究也是單細胞組學的應用領域。

市場區隔
類型 基因組學、轉錄組學、蛋白質組學、代謝體學
產品 設備、耗材和試劑、軟體和服務
科技 微流體、質譜分析、次世代定序、蛋白質微陣列
目的 腫瘤學、細胞生物學、免疫學、神經病學及其他
最終用戶 學術和研究機構、製藥和生物技術公司、醫院和診斷檢查室、合約研究組織
裝置 單細胞定序儀、單細胞分析儀等。

在單細胞體學市場中，產品細分包括儀器、耗材和試劑以及軟體和服務。耗材和試劑佔主導地位，因為它們是樣本製備、文庫建構和定序工作流程中持續必需的，預計到2025年，其市場規模將達到約4.708億美元。定序平台、流式細胞儀和微流體系統等儀器構成了單細胞分析基礎設施的核心。軟體和服務的重要性日益凸顯，因為它們能夠實現複雜資料集的高階資料分析、視覺化和解讀。人工智慧和生物資訊工具的整合進一步提高了研究效率，從而支持全球生命科學領域進行可擴展且高精度的單細胞研究。

區域概覽

北美是單細胞體學領域最大的區域市場，預計到2025年將佔全球市場佔有率的約43.68%。這得益於其強大的研究基礎設施、充足的資金籌措以及對先進基因組技術的早期應用。許多大型生物技術和製藥公司的存在，以及美國國立衛生研究院（NIH）等機構的大力支持，持續推動創新和大規模研究舉措的發展。此外，該地區完善的醫療保健體係以及對精準醫療和癌症研究日益成長的興趣也為其發展提供了助力。

亞太地區是成長最快的市場，預計在預測期內將以約16.7%的複合年成長率成長。這一成長主要得益於政府對基因組學和生命科學領域投資的增加、醫療保健支出的成長以及研究基礎設施的快速發展。中國、日本和印度等國家正積極推動精準醫療和大規模人群基因組分析計畫。此外，該地區龐大的患者群體、慢性病盛行率的上升以及生物技術產業的蓬勃發展，都在加速單細胞體學技術的應用。

主要趨勢和促進因素

創新驅動單細胞分析

在對高通量、擴充性且經濟高效的分析技術的需求驅動下，單細胞體學市場正經歷快速創新。研究人員擴大採用先進平台，以實現更深入的細胞層面洞察、多組體學整合，並支持腫瘤學和藥物研發等領域的大規模研究。此外，人們對能夠降低成本、擴大應用範圍並提高效率和數據準確性的自動化解決方案也越來越感興趣。例如，10x Genomics 於 2025 年 10 月推出了其新一代 Flex 檢測技術，該技術每周可分析多達 1 億個細胞。這凸顯了市場對高通量、高解析度單細胞分析解決方案日益成長的需求。

在藥物發現和生物標記鑑定中的應用日益廣泛

單細胞體學在藥物發現和生物標記鑑定的應用日益廣泛，是推動市場成長的主要動力。這些技術整合了基因組學、轉錄組學和蛋白​​質組學，能夠精準識別細胞類型特異性藥物靶點，並加深對複雜疾病機制的理解。單細胞RNA定序能夠產生高解析度數據，幫助研究人員分析細胞異質性，並改善臨床試驗結果。此外，人工智慧驅動的大型資料集分析有助於預測治療反應和疾病進展，從而提高藥物發現的效率。例如，2025年2月，印度理工學院馬德拉斯分校推出了SCOT實驗室，旨在加速基於單一細胞的藥物發現和早期診斷，凸顯了單細胞組學在精準醫療領域日益成長的應用潛力。

目錄

第1章摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依最終用戶分類
    • 學術和研究機構
    • 製藥和生物技術公司
    • 醫院和診斷檢測機構
    • CRO
  • 市場規模及預測：依應用領域分類
    • 腫瘤學
    • 細胞生物學
    • 免疫學
    • 神經病學
    • 其他
  • 市場規模及預測：依類型
    • 基因組學
    • 轉錄組學
    • 蛋白質體學
    • 代謝體學
  • 市場規模及預測：依產品分類
    • 裝置
    • 耗材和試劑
    • 軟體服務
  • 市場規模及預測：依設備分類
    • 單細胞定序儀
    • 單細胞分析儀
    • 其他
  • 市場規模及預測：依技術分類
    • 微流體技術
    • 質譜分析
    • 次世代定序
    • 蛋白質微陣列

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • 10x Genomics
  • Illumina, Inc.
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.
  • Precision Cell Systems, Inc.
  • Bio-Rad Laboratories, Inc.
  • Precigenome LLC
  • Becton, Dickinson and Company
  • Pacific Biosciences
  • Menarini Group
  • PerkinElmer
  • Takara Bio
  • Bruker
  • Danaher Corporation（Cytiva）
  • QIAGEN（Parse Biosciences）
  • Zifo
  • MISSION BIO
  • BICO（CELLENION）
  • CelLBxHealth（ANGLE plc.）
  • Creative Biolabs

第9章 關於我們

簡介目錄
Product Code: GIS25759

The global Single-cell Omics Market is projected to grow from $2.2 billion in 2025 to $7.8 billion by 2035, at a compound annual growth rate (CAGR) of 13.5%. The global single-cell omics market is supported by expanding investments in genomics and precision medicine. According to the National Institutes of Health (NIH, 2025), the U.S. allocated over $3.8 billion annually toward genomics and related research programs, including single-cell studies. The World Health Organization (WHO, 2024) reports more than 20 million new cancer cases globally, increasing demand for single-cell analysis in oncology. Additionally, the European Commission (Horizon Europe, 2025) has committed around $96 billion toward research and innovation, including life sciences and omics technologies. Furthermore, the UK Biobank (2025) continues to expand its dataset beyond 500,000 participants, supporting large-scale single-cell and genomic research initiatives.

In the single-cell omics market, the application segment includes oncology, cell biology, immunology, neurology, and other research areas. Oncology dominates the market, accounting for approximately $451.1 Million in 2025, driven by increasing use of single-cell sequencing for tumor heterogeneity analysis, biomarker discovery, and precision oncology applications. Cell biology focuses on understanding cellular structure, function, and gene expression at single-cell resolution. Immunology applications are expanding rapidly as researchers study immune cell dynamics, disease mechanisms, and vaccine responses. Neurology is also gaining traction with rising research into brain disorders and neural mapping, while other applications include developmental and infectious disease studies.

Market Segmentation
TypeGenomics, Transcriptomics, Proteomics, Metabolomics
ProductInstruments, Consumables & Reagents, Software & Services
TechnologyMicrofluidics, Mass Spectrometry, Next-Generation Sequencing, Protein Microarrays
ApplicationOncology, Cell Biology, Immunology, Neurology, Others
End-UserAcademic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories, CROs
InstrumentsSingle-Cell Sequencers, Single-Cell Analyzers, Others

In the single-cell omics market, the product segment includes instruments, consumables & reagents, and software & services. Consumables & reagents dominate the segment, accounting for approximately $470.8 Million in 2025, due to their continuous requirement in sample preparation, library construction, and sequencing workflows. Instruments such as sequencing platforms, flow cytometers, and microfluidics systems form the core of single-cell analysis infrastructure. Software & services are increasingly important, enabling advanced data analysis, visualization, and interpretation of complex datasets. The integration of AI and bioinformatics tools is further enhancing research efficiency, supporting scalable and high-precision single-cell studies across global life science applications.

Geographical Overview

North America is the largest regional market for single-cell omics, accounting for approximately 43.68% of the global market share in 2025, supported by strong research infrastructure, high funding levels, and early adoption of advanced genomic technologies. The presence of leading biotechnology and pharmaceutical companies, along with extensive support from organizations such as the National Institutes of Health, continues to drive innovation and large-scale research initiatives. The region also benefits from a well-established healthcare system and growing focus on precision medicine and cancer research.

The Asia-Pacific region is the fastest-growing market, projected to expand at a CAGR of approximately 16.7% during the forecast period. This growth is driven by increasing government investments in genomics and life sciences, rising healthcare expenditure, and rapid development of research infrastructure. Countries such as China, Japan, and India are actively promoting precision medicine and large-scale population genomics programs. Additionally, the region's large patient base, growing prevalence of chronic diseases, and expanding biotechnology sector are accelerating the adoption of single-cell omics technologies.

Key Trends and Drivers

Innovations Driving Single-Cell Analysis

The single-cell omics market is witnessing rapid innovation driven by the need for high-throughput, scalable, and cost-efficient analysis technologies. Researchers are increasingly adopting advanced platforms that enable deeper cellular insights, integration of multiomics, and support for large-scale studies in areas such as oncology and drug discovery. The focus is also shifting toward automation-ready solutions that improve efficiency and data accuracy while reducing costs for broader accessibility. For instance, in October 2025, 10x Genomics launched its next-generation Flex assay, enabling analysis of up to 100 million cells per week, highlighting the growing demand for high-volume, high-resolution single-cell analysis solutions.

Increasing Use in Drug Discovery and Biomarker Identification

The increasing use of single-cell omics in drug discovery and biomarker identification is a key driver of market growth. These technologies enable precise identification of cell-type-specific drug targets and deeper understanding of complex disease mechanisms by integrating genomics, transcriptomics, and proteomics. Single-cell RNA sequencing generates high-resolution data, helping researchers analyze cellular heterogeneity and improve clinical trial outcomes. Additionally, AI-driven analysis of large datasets supports prediction of therapeutic responses and disease progression, enhancing drug development efficiency. For instance, in February 2025, IIT Madras launched the SCOT Lab to accelerate single-cell-based drug discovery and early diagnostics, highlighting growing adoption in precision medicine.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by End-User
  • 2.2 Key Market Highlights by Application
  • 2.3 Key Market Highlights by Type
  • 2.4 Key Market Highlights by Product
  • 2.5 Key Market Highlights by Instruments
  • 2.6 Key Market Highlights by Technology

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTLE Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by End-User (2020-2035)
    • 4.1.1 Academic & Research Institutes
    • 4.1.2 Pharmaceutical & Biotechnology Companies
    • 4.1.3 Hospital & Diagnostic Laboratories
    • 4.1.4 CROs
  • 4.2 Market Size & Forecast by Application (2020-2035)
    • 4.2.1 Oncology
    • 4.2.2 Cell Biology
    • 4.2.3 Immunology
    • 4.2.4 Neurology
    • 4.2.5 Others
  • 4.3 Market Size & Forecast by Type (2020-2035)
    • 4.3.1 Genomics
    • 4.3.2 Transcriptomics
    • 4.3.3 Proteomics
    • 4.3.4 Metabolomics
  • 4.4 Market Size & Forecast by Product (2020-2035)
    • 4.4.1 Instruments
    • 4.4.2 Consumables & Reagents
    • 4.4.3 Software & Services
  • 4.5 Market Size & Forecast by Instruments (2020-2035)
    • 4.5.1 Single-Cell Sequencers
    • 4.5.2 Single-Cell Analyzers
    • 4.5.3 Others
  • 4.6 Market Size & Forecast by Technology (2020-2035)
    • 4.6.1 Microfluidics
    • 4.6.2 Mass Spectrometry
    • 4.6.3 Next-Generation Sequencing
    • 4.6.4 Protein Microarrays

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Instruments
      • 5.2.1.5 Application
      • 5.2.1.6 End-User
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Instruments
      • 5.2.2.5 Application
      • 5.2.2.6 End-User
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Instruments
      • 5.2.3.5 Application
      • 5.2.3.6 End-User
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Instruments
      • 5.3.1.5 Application
      • 5.3.1.6 End-User
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Instruments
      • 5.3.2.5 Application
      • 5.3.2.6 End-User
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Instruments
      • 5.3.3.5 Application
      • 5.3.3.6 End-User
  • 5.4 Europe Market Size (2020-2035)
    • 5.4.1 Germany
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Instruments
      • 5.4.1.5 Application
      • 5.4.1.6 End-User
    • 5.4.2 France
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Instruments
      • 5.4.2.5 Application
      • 5.4.2.6 End-User
    • 5.4.3 United Kingdom
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Instruments
      • 5.4.3.5 Application
      • 5.4.3.6 End-User
    • 5.4.4 Spain
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Instruments
      • 5.4.4.5 Application
      • 5.4.4.6 End-User
    • 5.4.5 Italy
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Instruments
      • 5.4.5.5 Application
      • 5.4.5.6 End-User
    • 5.4.6 Rest of Europe
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Instruments
      • 5.4.6.5 Application
      • 5.4.6.6 End-User
  • 5.5 Asia-Pacific Market Size (2020-2035)
    • 5.5.1 China
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Instruments
      • 5.5.1.5 Application
      • 5.5.1.6 End-User
    • 5.5.2 India
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Instruments
      • 5.5.2.5 Application
      • 5.5.2.6 End-User
    • 5.5.3 South Korea
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Instruments
      • 5.5.3.5 Application
      • 5.5.3.6 End-User
    • 5.5.4 Japan
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Instruments
      • 5.5.4.5 Application
      • 5.5.4.6 End-User
    • 5.5.5 Australia
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Instruments
      • 5.5.5.5 Application
      • 5.5.5.6 End-User
    • 5.5.6 Taiwan
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Instruments
      • 5.5.6.5 Application
      • 5.5.6.6 End-User
    • 5.5.7 Rest of APAC
      • 5.5.7.1 Type
      • 5.5.7.2 Product
      • 5.5.7.3 Technology
      • 5.5.7.4 Instruments
      • 5.5.7.5 Application
      • 5.5.7.6 End-User
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Instruments
      • 5.6.1.5 Application
      • 5.6.1.6 End-User
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Instruments
      • 5.6.2.5 Application
      • 5.6.2.6 End-User
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Instruments
      • 5.6.3.5 Application
      • 5.6.3.6 End-User
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Instruments
      • 5.6.4.5 Application
      • 5.6.4.6 End-User
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Instruments
      • 5.6.5.5 Application
      • 5.6.5.6 End-User

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 10x Genomics
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Illumina, Inc.
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Standard BioTools Inc.
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Thermo Fisher Scientific Inc.
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Precision Cell Systems, Inc.
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Bio-Rad Laboratories, Inc.
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Precigenome LLC
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Becton, Dickinson and Company
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Pacific Biosciences
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Menarini Group
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 PerkinElmer
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Takara Bio
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Bruker
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Danaher Corporation (Cytiva)
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 QIAGEN (Parse Biosciences)
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Zifo
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 MISSION BIO
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 BICO (CELLENION)
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 CelLBxHealth (ANGLE plc.)
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Creative Biolabs
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us